#VisualAbstract: Oral Nirmatrelvir-Ritonavir Postexposure Prophylaxis Does Not Reduce the Risk of Developing Symptomatic Covid-19
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. In this randomized controlled trial, cyclophosphamide-tacrolimus-mycophenolate mofetil was associated with lower rates of graft-versus-host disease (GVHD) compared to ...
1. In this randomized controlled trial, a single dose of azithromycin reduced the risk of maternal sepsis or death among ...
1. In this double-blind, randomized trial, hydroxychloroquine did not reduce symptom severity in an adult, outpatient population. 2. More side ...
1. Maraviroc pre-exposure prophylaxis regimens were observed to be safe and well tolerated in patients. 2. No new HIV infections ...
1. For patients who received pre-exposure prophylaxis delivered through sexual health clinics in the United States, the adherence rate was ...
Image: PD 1. High-dose prophylaxis for severe hemophilia increases total cost of care. 2. Compared to intermediate-doses, high-dose prophylaxis reduces bleeding ...
Image: PD 1. Short-term zinc prophylaxis in infants is associated with decreased morbidity from diarrheal episodes. 2. In those infants ...
In this section, we will highlight the some of the key high-impact studies, updates, and analyses published in the past ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.